Synthetic Lethal Vulnerabilities in KRAS -Mutant Cancers

Cold Spring Harbor Perspectives in Medicine
Andrew J Aguirre, William C Hahn

Abstract

KRAS is the most commonly mutated oncogene in human cancer. Most KRAS-mutant cancers depend on sustained expression and signaling of KRAS, thus making it a high-priority therapeutic target. Unfortunately, development of direct small molecule inhibitors of KRAS function has been challenging. An alternative therapeutic strategy for KRAS-mutant malignancies involves targeting codependent vulnerabilities or synthetic lethal partners that are preferentially essential in the setting of oncogenic KRAS. KRAS activates numerous effector pathways that mediate proliferation and survival signals. Moreover, cancer cells must cope with substantial oncogenic stress conferred by mutant KRAS. These oncogenic signaling pathways and compensatory coping mechanisms of KRAS-mutant cancer cells form the basis for synthetic lethal interactions. Here, we review the compendium of previously identified codependencies in KRAS-mutant cancers, including the results of numerous functional genetic screens aimed at identifying KRAS synthetic lethal targets. Importantly, many of these vulnerabilities may represent tractable therapeutic opportunities.

References

Sep 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·A SjölanderE G Lapetina
Dec 20, 1994·Proceedings of the National Academy of Sciences of the United States of America·M Spaargaren, J R Bischoff
Nov 1, 1994·Molecular and Cellular Biology·A KikuchiL T Williams
Nov 8, 1994·Proceedings of the National Academy of Sciences of the United States of America·F HoferG S Martin
Aug 18, 1994·Nature·P Rodriguez-VicianaJ Downward
Aug 17, 2002·Genes & Development·Nesrin M HamadChristopher M Counter
Jun 14, 2005·Cancer Cell·Kian-Huat LimChristopher M Counter
Aug 20, 2005·Nature Reviews. Cancer·William G Kaelin
Jan 24, 2007·Molecular Cancer Therapeutics·Aparna V SarthyStephen W Fesik
Mar 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·Katrina PodsypaninaHarold E Varmus
Apr 9, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alex A AdjeiS Gail Eckhardt
Dec 19, 2008·Proceedings of the National Academy of Sciences of the United States of America·Biao LuoDavid E Root
Apr 22, 2010·Cancer Research·Daniela S BassèresAlbert S Baldwin
Oct 26, 2010·The Journal of Clinical Investigation·Silvestre VicentE Alejandro Sweet-Cordero
Dec 2, 2010·Molecular Biology of the Cell·Rebecca LockJayanta Debnath
Feb 15, 2011·Genes & Development·Jessie Yanxiang GuoEileen White
Mar 17, 2011·Genes & Development·Shenghong YangAlec C Kimmelman
May 11, 2011·Proceedings of the National Academy of Sciences of the United States of America·Alice T ShawTyler Jacks
Jun 18, 2011·Nature Reviews. Genetics·Jesse S Boehm, William C Hahn
Jul 12, 2011·Cancer Research·Carol BabijIsabelle Dussault
Jul 13, 2011·Proceedings of the National Academy of Sciences of the United States of America·Hiu Wing CheungWilliam C Hahn
Aug 5, 2011·Nature·Johannes ZuberChristopher R Vakoc

❮ Previous
Next ❯

Citations

Aug 6, 2017·Cold Spring Harbor Perspectives in Medicine·Anica Wandler, Kevin Shannon
Aug 19, 2020·Journal of Hematology & Oncology·Jimin YuanJiancheng Hu
Dec 19, 2019·Cancers·Patrícia Dias CarvalhoSérgia Velho
Apr 2, 2020·Expert Opinion on Drug Discovery·M Shahar YarAhmed Kamal
Aug 17, 2020·The Biochemical Journal·Walaa E Kattan, John F Hancock
Jun 30, 2018·Nature Reviews. Clinical Oncology·Alan Ashworth, Christopher J Lord
Nov 20, 2019·International Journal of Molecular Sciences·Veronica Aran, Jasminka Omerovic
Jun 27, 2019·Journal of Clinical Medicine·Yu-Hsuan HungMei-Ren Pan
Jun 18, 2020·Cancer Metastasis Reviews·Aron GhimessyZsolt Megyesfalvi
Sep 20, 2020·Cancer Gene Therapy·Francesco PalmaCristina Quintavalle
Sep 16, 2020·Nature Biotechnology·Joshua BroydeAndrea Califano
Nov 23, 2019·Der Pathologe·R Schäfer
Nov 3, 2020·Nucleic Acids Research·Ahyoung ChoiSanghyuk Lee
Apr 12, 2020·Molecular Cancer Research : MCR·Josh Lewis SternFranklin W Huang
Nov 27, 2020·Computational and Structural Biotechnology Journal·Li GuoTingming Liang
Jan 11, 2021·Trends in Pharmacological Sciences·Dexter Kai Hao ThngEdward Kai-Hua Chow
May 27, 2020·Journal of Advanced Research·Jin'en WuYadong Zheng
Mar 8, 2021·Seminars in Oncology·Ji Luo
Mar 30, 2021·Frontiers in Oncology·Valeria MerzDavide Melisi
Apr 22, 2021·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Aslamuzzaman KaziSaïd M Sebti
Aug 8, 2021·Cancers·Anxo Rio-VilariñoArancha Cebrián
Jun 20, 2020·Cancer Cell·Luisa F Escobar-HoyosSteven D Leach
Aug 22, 2021·Science Advances·Yu-Chiao ChiuYidong Chen
Oct 5, 2021·Future Medicinal Chemistry·Siying Zhong, Joanne Wayne
Oct 8, 2021·Communications Biology·Josephine T DaubPatrick Kemmeren

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.